All India Investors

Share this post
Mumbai Based Hexagon Nutrition Files For ₹ 600 Crore IPO With SEBI
www.allindiainvestors.com

Mumbai Based Hexagon Nutrition Files For ₹ 600 Crore IPO With SEBI

Harshita Sharma
Dec 24, 2021
Share this post
Mumbai Based Hexagon Nutrition Files For ₹ 600 Crore IPO With SEBI
www.allindiainvestors.com
Hexagon Nutrition IPO
Representational Image | Credit: Freepik

Mumbai-based Hexagon Nutrition has filed draft papers with market regulator SEBI with an aim to raise ₹ 600 crore via an Initial Public Offering (IPO).

The share sale consists of a fresh issue of equity shares worth ₹ 100 crore, and an offer for sale (OFS) aggregating up to 30,113,918 equity shares, as per the draft red herring prospectus (DRHP).

The issue size will be between in the range of ₹ 500-600 crore. The proceeds from the fresh issue will be directed towards paying off debt, financing incremental working capital requirements, supporting capital expenditure needs to expand the already existing facility, investment in subsidiaries and funding capital expenditure at the existing facility, and general corporate purposes.

Hexagon Nutrition was founded by Arun and Subash Kelkar. In 1993, it became one of the top micronutrient formulations companies, creating brands like Pentasure, Obesigo, and Pediagold, which are now household names in the health, wellness, and clinical nutrition industries.

In 2016, offshore private equity firm Somerset Indus Healthcare Fund-I plus Mayur Anand Sardesai, director at Somerset Health Capital Advisors poured in ₹ 25 crore to own a 10 per cent stake in the company.

Hexagon Nutrition established a trading company in South Africa in 2019. In addition, Hexagon is setting up a factory in Uzbekistan, which is expected to open in the first quarter of 2022. The issue's book-running lead managers are Equirus Capital and SBI Capital Markets.

Share this post
Mumbai Based Hexagon Nutrition Files For ₹ 600 Crore IPO With SEBI
www.allindiainvestors.com
Comments

Create your profile

0 subscriptions will be displayed on your profile (edit)

Skip for now

Only paid subscribers can comment on this post

Already a paid subscriber? Sign in

Check your email

For your security, we need to re-authenticate you.

Click the link we sent to , or click here to sign in.

TopNew

No posts

Ready for more?

© 2022 All India Investors
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing